human neuro discovery array c1  (RayBiotech)


Bioz Verified Symbol RayBiotech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 78
    Name:
    Human Neuro Discovery Array C1
    Description:
    RayBio C Series Human Neuro Discovery Array C1 Kit Detects 20 human neurologically relevant proteins Suitable for serum plasma cell culture media and other liquid sample types
    Catalog Number:
    aah-neu-1-2
    Price:
    372.0
    Applications:
    Multiplexed Protein Detection; Detection of Relative Protein Expression; Detecting Patterns of Cytokine Expression; Biomarker/ Key Factor Screening; Identifying Key Factors; Confirming a Biological Process
    Size:
    2 Sample Kit
    Category:
    C Series Membrane Based Arrays
    Reactivity:
    Human
    Buy from Supplier


    Structured Review

    RayBiotech human neuro discovery array c1
    Human Neuro Discovery Array C1
    RayBio C Series Human Neuro Discovery Array C1 Kit Detects 20 human neurologically relevant proteins Suitable for serum plasma cell culture media and other liquid sample types
    https://www.bioz.com/result/human neuro discovery array c1/product/RayBiotech
    Average 78 stars, based on 2 article reviews
    Price from $9.99 to $1999.99
    human neuro discovery array c1 - by Bioz Stars, 2020-01
    78/100 stars

    Related Products / Commonly Used Together

    ox-ldls
    endometrial cells

    Images

    1) Product Images from "Redox regulation of microRNAs in endometriosis-associated pain"

    Article Title: Redox regulation of microRNAs in endometriosis-associated pain

    Journal: Redox Biology

    doi: 10.1016/j.redox.2017.04.037

    Protein array of inflammatory and nociceptive targets: The RayBiotech Human Neuro Discovery Array C1 was used to determine the expression of 20 human immunomodulators in treated endometrial cells. A) Heat map showing relative expression of inflammatory and nociceptive proteins in endometrial cells treated with PF and ox-LDLs (n=3). PF was obtained from patients with neither endometriosis nor pain (PF-NN, n=6), with endometriosis and pain (PF-YY, n=6), and with endometriosis and no pain (PF-YN, n=4). B) Fold change ratio for MCP1 and Mip1a was calculated in comparison to media control (n=4). While cells treated with PF-YY typically had cytokine expression that was lower than or similar to other cells treatment groups, MCP1 and Mip1α showed an exaggerated increased trend. A similar trend was seen in protein from cells treated with ox-LDLs, particularly native LDL (L0). Two-way ANOVA determined p > 0.05.
    Figure Legend Snippet: Protein array of inflammatory and nociceptive targets: The RayBiotech Human Neuro Discovery Array C1 was used to determine the expression of 20 human immunomodulators in treated endometrial cells. A) Heat map showing relative expression of inflammatory and nociceptive proteins in endometrial cells treated with PF and ox-LDLs (n=3). PF was obtained from patients with neither endometriosis nor pain (PF-NN, n=6), with endometriosis and pain (PF-YY, n=6), and with endometriosis and no pain (PF-YN, n=4). B) Fold change ratio for MCP1 and Mip1a was calculated in comparison to media control (n=4). While cells treated with PF-YY typically had cytokine expression that was lower than or similar to other cells treatment groups, MCP1 and Mip1α showed an exaggerated increased trend. A similar trend was seen in protein from cells treated with ox-LDLs, particularly native LDL (L0). Two-way ANOVA determined p > 0.05.

    Techniques Used: Protein Array, Expressing

    2) Product Images from "Redox regulation of microRNAs in endometriosis-associated pain"

    Article Title: Redox regulation of microRNAs in endometriosis-associated pain

    Journal: Redox Biology

    doi: 10.1016/j.redox.2017.04.037

    Protein array of inflammatory and nociceptive targets: The RayBiotech Human Neuro Discovery Array C1 was used to determine the expression of 20 human immunomodulators in treated endometrial cells. A) Heat map showing relative expression of inflammatory and nociceptive proteins in endometrial cells treated with PF and ox-LDLs (n=3). PF was obtained from patients with neither endometriosis nor pain (PF-NN, n=6), with endometriosis and pain (PF-YY, n=6), and with endometriosis and no pain (PF-YN, n=4). B) Fold change ratio for MCP1 and Mip1a was calculated in comparison to media control (n=4). While cells treated with PF-YY typically had cytokine expression that was lower than or similar to other cells treatment groups, MCP1 and Mip1α showed an exaggerated increased trend. A similar trend was seen in protein from cells treated with ox-LDLs, particularly native LDL (L0). Two-way ANOVA determined p > 0.05.
    Figure Legend Snippet: Protein array of inflammatory and nociceptive targets: The RayBiotech Human Neuro Discovery Array C1 was used to determine the expression of 20 human immunomodulators in treated endometrial cells. A) Heat map showing relative expression of inflammatory and nociceptive proteins in endometrial cells treated with PF and ox-LDLs (n=3). PF was obtained from patients with neither endometriosis nor pain (PF-NN, n=6), with endometriosis and pain (PF-YY, n=6), and with endometriosis and no pain (PF-YN, n=4). B) Fold change ratio for MCP1 and Mip1a was calculated in comparison to media control (n=4). While cells treated with PF-YY typically had cytokine expression that was lower than or similar to other cells treatment groups, MCP1 and Mip1α showed an exaggerated increased trend. A similar trend was seen in protein from cells treated with ox-LDLs, particularly native LDL (L0). Two-way ANOVA determined p > 0.05.

    Techniques Used: Protein Array, Expressing

    Related Articles

    Incubation:

    Article Title: Redox regulation of microRNAs in endometriosis-associated pain
    Article Snippet: The Human Neuro Discovery Array C1 (RayBiotech, Inc., Norcross, GA), which includes 20 human neurologically relevant proteins belonging to immune response and inflammation pathways was used for the detection of changes in target proteins. .. Following washing, the membranes were then incubated with a biotinylated detection antibody cocktail overnight (4 °C), washed, and incubated with horseradish peroxidase (HRP)-conjugated streptavidin.

    Imaging:

    Article Title: Redox regulation of microRNAs in endometriosis-associated pain
    Article Snippet: The Human Neuro Discovery Array C1 (RayBiotech, Inc., Norcross, GA), which includes 20 human neurologically relevant proteins belonging to immune response and inflammation pathways was used for the detection of changes in target proteins. .. Following additional washing steps, the membrane was incubated in the detection buffer followed by imaging of the developed proteins using the ChemiDoc system (Biorad).

    Expressing:

    Article Title: Redox regulation of microRNAs in endometriosis-associated pain
    Article Snippet: The protein levels of genes involved in nociceptive and inflammatory pathways were measured in endometrial cells treated with PF or ox-LDLs using the Human Neuro Discovery Array (Ray Biotech, Inc.). .. As shown in the heat map ( A ), many cytokines had similar expression across all treatment groups except for MCP1 (CCL2) and monocyte inflammatory protein-Mip1α (CCL3).

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 78
    RayBiotech human neuro discovery array c1
    Protein array of inflammatory and nociceptive targets: The RayBiotech Human <t>Neuro</t> Discovery <t>Array</t> C1 was used to determine the expression of 20 human immunomodulators in treated endometrial cells. A) Heat map showing relative expression of inflammatory and nociceptive proteins in endometrial cells treated with PF and ox-LDLs (n=3). PF was obtained from patients with neither endometriosis nor pain (PF-NN, n=6), with endometriosis and pain (PF-YY, n=6), and with endometriosis and no pain (PF-YN, n=4). B) Fold change ratio for MCP1 and Mip1a was calculated in comparison to media control (n=4). While cells treated with PF-YY typically had cytokine expression that was lower than or similar to other cells treatment groups, MCP1 and Mip1α showed an exaggerated increased trend. A similar trend was seen in protein from cells treated with ox-LDLs, particularly native LDL (L0). Two-way ANOVA determined p > 0.05.
    Human Neuro Discovery Array C1, supplied by RayBiotech, used in various techniques. Bioz Stars score: 78/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human neuro discovery array c1/product/RayBiotech
    Average 78 stars, based on 2 article reviews
    Price from $9.99 to $1999.99
    human neuro discovery array c1 - by Bioz Stars, 2020-01
    78/100 stars
      Buy from Supplier

    N/A
    RayBio C Series Human Neuro Discovery Array C2 Kit Detects 30 human neurologically relevant proteins Suitable for serum plasma cell culture media and other liquid sample types
      Buy from Supplier

    Image Search Results


    Protein array of inflammatory and nociceptive targets: The RayBiotech Human Neuro Discovery Array C1 was used to determine the expression of 20 human immunomodulators in treated endometrial cells. A) Heat map showing relative expression of inflammatory and nociceptive proteins in endometrial cells treated with PF and ox-LDLs (n=3). PF was obtained from patients with neither endometriosis nor pain (PF-NN, n=6), with endometriosis and pain (PF-YY, n=6), and with endometriosis and no pain (PF-YN, n=4). B) Fold change ratio for MCP1 and Mip1a was calculated in comparison to media control (n=4). While cells treated with PF-YY typically had cytokine expression that was lower than or similar to other cells treatment groups, MCP1 and Mip1α showed an exaggerated increased trend. A similar trend was seen in protein from cells treated with ox-LDLs, particularly native LDL (L0). Two-way ANOVA determined p > 0.05.

    Journal: Redox Biology

    Article Title: Redox regulation of microRNAs in endometriosis-associated pain

    doi: 10.1016/j.redox.2017.04.037

    Figure Lengend Snippet: Protein array of inflammatory and nociceptive targets: The RayBiotech Human Neuro Discovery Array C1 was used to determine the expression of 20 human immunomodulators in treated endometrial cells. A) Heat map showing relative expression of inflammatory and nociceptive proteins in endometrial cells treated with PF and ox-LDLs (n=3). PF was obtained from patients with neither endometriosis nor pain (PF-NN, n=6), with endometriosis and pain (PF-YY, n=6), and with endometriosis and no pain (PF-YN, n=4). B) Fold change ratio for MCP1 and Mip1a was calculated in comparison to media control (n=4). While cells treated with PF-YY typically had cytokine expression that was lower than or similar to other cells treatment groups, MCP1 and Mip1α showed an exaggerated increased trend. A similar trend was seen in protein from cells treated with ox-LDLs, particularly native LDL (L0). Two-way ANOVA determined p > 0.05.

    Article Snippet: The Human Neuro Discovery Array C1 (RayBiotech, Inc., Norcross, GA), which includes 20 human neurologically relevant proteins belonging to immune response and inflammation pathways was used for the detection of changes in target proteins.

    Techniques: Protein Array, Expressing